MPV

BECIS announces US$53 million in new equity financing from shareholders to support continued growth in Solar, Bioenergy and New Solutions business segments

SINGAPORE,Dec. 9,2024--BE C&I Solutions Holding Pte. Ltd. ("BECIS") is pleased to announce US$53 million in new equity financing from existing shareholders,namely FMO,KLP Norfund Invest

12-10 BECIS

AXA and HK Express Launch New Flight Delay Parametric Protection

More Travel Protection Products for Better Flexibility Expanding into More Markets HONG KONG,Dec. 9,2024-- AXA Hong Kong and Macau (AXA) and HK Express Airways (HK Express),with the support of AXA Par

12-10 AXA Hong Kong and Macau

Seoul National University Bundang Hospital Establishes the first "International PSP Research and Treatment Center" in Korea

MOU Signed Among SNUBH-CurePSP-GemVax for the Establishment of International PSP Research and Treatment Center

12-10 GemVax & KAEL

NTT Group Chooses Evidian Identity Governance & Administration as the Cornerstone of their Identity Management Infrastructure in Japan

One of the largest IGA deployments in Japan,ensuring governance and scalability for identity and rights management for 250 000 employees within the NTT Group

12-10 Eviden

Capture, Celebrate, and Save Big: Reolink's Holiday Deals and #reocap Fun!

LOSANGELES,Dec. 10,2024-- This holiday season,Reolink,an innovative leader in intelligent visual technology for the home,is extending warm wishes for a joyful and safe celebration. With heartfelt cel

12-10 Reolink Innovation Inc.

Daewoong Pharmaceutical Captivates Global Experts at AMWC-SEA with 'Nabolift,' Redefining Toxin Treatments

- At "AMWC SEA 2024," one of the world\'s top three aesthetic medicine congresses,the Nabota booth attracted over 500 visitors.

12-06 Daewoong Pharmaceutical Co., Ltd

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing

EAST RUTHERFORD,N.J.,Dec. 5,2024--Cambrex,a leading global contract development and manufacturing organization (CDMO),announced today that it has signed an agreement with Eli Lilly and Company (Lilly

12-06 Cambrex

SD Biosensor Signs Tripartite MOU for R&D of New Products for Extensively Drug-Resistant Tuberculosis with Japan's RIT/JATA and Korea's International Tuberculosis Research Center

SD Biosensor strengthens its new product lineup with the POC molecular diagnostic platform M10 Early detection of patients is expected to contribute to the eradication of tuberculosis in high-risk Asi

12-06 SD Biosensor

Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area

OSAKA,Japan and MONTREAL,Dec. 6,2024-- Ono Pharmaceutical Co.,Ltd. (Headquarters: Osaka,Japan; President:ToichiTakino; "Ono") announced that it has entered into a drug discovery collaborati

12-06 Ono Pharmaceutical co., ltd.

SKF to showcase innovative solutions at the Tech and Innovation summit

GOTHENBURG,Sweden,Dec. 4,2024-- SKF to unveil a broad range of products and solutions to continue serving customers with more efficient,reliable,and sustainable technologies. You are welcome to join t

12-05 SKF